Research Protocol · Live
Vial · 80 mg
Research duration
Per vial
Cadence
DAILYPer dose
3 mg
Per-administration dose
◀ DRAG TO SCRUB ▶
KLOW 80mgResearch Peptide
Four-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
Assayed Purity
99.00%
Method
HPLC
Certificate
Coming soon$2.50 / mg
Not eligible for Mystery Week
This product stays at its regular or volume price.
In stock, ships from Sydney
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Four-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
KLOW is a combination research blend of four peptides studied for overlapping regenerative and cytoprotective pathways: GHK-Cu (50mg), the copper tripeptide associated in published work with collagen and elastin synthesis, antioxidant activity and broad gene-expression modulation; BPC-157 (10mg), a gastric pentadecapeptide investigated for angiogenesis and tendon, ligament and gut-lining repair in animal models; TB-500 (10mg), a thymosin β-4 fragment studied for actin-cytoskeleton regulation and cell migration in tissue-repair research; and KPV (10mg), the C-terminal α-MSH tripeptide associated with NF-κB pathway inhibition and reduced inflammatory cytokine secretion. The blend is supplied lyophilised, 80mg total per vial. For research use only. Not for human consumption.
